Compared with usual care, a mid-trimester blood test designed to predict preterm birth for average-risk women markedly reduced neonatal morbidity when paired with a three-step treatment bundle, ...

Zolpidem is included in category B of the US FDA classification as regards the risk of drug use in pregnant women (its ... for long periods of time (>6 months). Elderly patients.